Ethics of Placebo-Controlled Trials of Zidovudine to Prevent the Perinatal Transmission of HIV in the Third World
Author:
- M H MersonMMM H Merson
- 19 March 1998
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 338 (12) , 836-841
Abstract
Lurie and Wolfe (Sept. 18 issue)1 claim that ongoing placebo-controlled trials of antiretroviral agents to reduce perinatal transmission of the human immunodeficiency virus (HIV) in developing countries are unethical. As executive director of the World Health Organization Global Program on AIDS, I convened the June 1994 meeting that considered how best to apply the impressive results of AIDS Clinical Trials Group (ACTG) study 076 in developing countries, where 90 percent of HIV infections occur. Twenty-eight experts from eight developed and six developing countries participated.Keywords
This publication has 13 references indexed in Scilit:
- Ethical Issues in Studies in Thailand of the Vertical Transmission of HIVNew England Journal of Medicine, 1998
- Ethical Complexities of Conducting Research in Developing CountriesNew England Journal of Medicine, 1997
- Unethical Trials of Interventions to Reduce Perinatal Transmission of the Human Immunodeficiency Virus in Developing CountriesNew England Journal of Medicine, 1997
- Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties1996
- Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral loadJAMA, 1996
- Efficacy of Antenatal Zidovudine in Reducing Perinatal Transmission of Human Immunodeficiency Virus Type 1The Journal of Infectious Diseases, 1995
- Effects of Zidovudine Use During Pregnancy on Resistance and Vertical Transmission of Human Immunodeficiency Virus Type 1Clinical Infectious Diseases, 1995
- Rates of Mother-to-Child Transmission of HIV-1 in Africa, America, and EuropeJAIDS Journal of Acquired Immune Deficiency Syndromes, 1995
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994
- Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast1994